Trevi Therapeutics TRVI Cash Flow Statement (2018-2026)

NASDAQ TRVI
$12.83 +0.93 (+7.82%)
At close: Oct 20, 2026 · 4:00 PM EDT
Reported Financials

Trevi Therapeutics Quarterly Cash Flow Statement

Periods 34 quarters
Latest Jun 2026

Trevi Therapeutics reported cash from operations of -$17.43M and free cash flow of -$17.55M for the quarter ended Jun 2026, down 72.5% year over year. This cash flow statement covers 34 quarters of results from Mar 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-7.26M-8.52M-7.33M-8.05M-8.27M-5.55M-6.40M-7.15M-7.70M-7.86M-10.90M-12.35M-13.24M-11.42M-10.34M-12.30M-11.80M-8.36M-13.19M-17.80M
Depreciation and DepletionDep. & Depletion
0.01M0.01M0.01M0.01M0.01M0.02M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
0.15M0.16M0.15M0.14M0.12M0.10M0.08M0.10M
Depreciation & Amortization (CF)Dep. & Amort.
0.01M0.01M0.01M0.01M0.01M0.02M0.02M0.03M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.03M0.03M0.03M
Share-based CompensationStock Comp.
0.54M0.54M0.74M0.52M0.57M0.50M0.58M0.53M0.53M0.53M0.72M1.13M0.82M0.92M1.21M1.38M1.24M1.35M2.19M3.27M
Gains from Sales and DivestituresGains Divest
-0.01M
Other non-cash itemsOther Non-Cash
0.03M-0.10M0.12M0.51M0.12M0.11M0.03M0.20M0.11M0.11M0.11M0.13M0.11M0.10M
Change in Working Capital
Change in ReceivablesChange Receivables
Change in Account PayablesChange Payables
-1.26M0.62M-1.11M2.05M-1.47M0.54M-0.91M-0.59M-0.17M0.63M0.29M-0.62M0.13M1.80M-1.99M1.55M-0.28M0.12M-1.48M-0.28M
Change in Accured ExpensesChange Accured Exp.
0.09M0.56M0.01M0.34M0.31M-1.30M-0.06M-0.73M0.82M0.02M-0.94M2.02M2.20M-0.71M-1.50M0.50M0.14M-0.56M-1.08M0.69M
Change in Other Operating AssetsOther Assets Change
-0.47M-0.46M-0.42M1.31M-0.31M0.02M0.84M1.65M0.45M-0.09M-0.58M-1.33M-0.82M0.08M0.61M1.00M0.03M-0.16M2.84M2.93M
Change in Other Operating LiabilitiesOther Liabilities Change
Other Working Capital ChangesOther WC Changes
0.47M0.46M0.42M-1.31M0.31M-0.02M-0.84M-1.65M-0.45M0.09M0.58M1.33M0.82M-0.08M-0.61M-1.00M-0.03M0.16M-2.84M-2.93M
Cash from OperationsCash from Ops.
-7.24M-6.23M-7.09M-6.18M-8.58M-6.33M-8.20M-9.88M-7.28M-6.36M-10.47M-8.68M-9.56M-9.55M-13.48M-10.10M-10.88M-7.63M-16.69M-17.43M
Investing Activities
Capital ExpendituresCapex
0.12M0.06M0.04M0.02M0.02M0.01M0.01M0.10M0.12M
Change in Property, Plant and EquipmentChange in PP&E
-0.12M-0.06M-0.04M-0.02M-0.02M-0.01M-0.01M-0.10M-0.12M
Purchase of InvestmentsInvestments Purchased
6.81M65.19M8.98M0.95M30.26M9.96M13.05M45.19M27.55M17.11M71.61M54.40M8.49M153.56M
Sale and Maturity of InvestmentsInvestments Sold
17.00M18.00M19.68M18.00M13.82M22.17M12.75M20.72M21.33M17.60M14.50M20.68M23.79M25.55M41.65M
Cash from Investing ActivitiesCash from Investing
-4.85M-48.31M8.96M19.64M17.98M12.85M-8.09M2.77M7.67M-23.87M-9.95M-2.61M-50.94M-30.61M16.97M-112.04M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt RepaymentsLT Debt Repayment
0.58M1.75M1.75M1.75M1.75M0.03M0.03M-9.38M0.03M0.03M0.03M0.03M0.01M
Non-Current Debt
-0.58M-1.75M-1.75M-1.75M-1.75M-0.03M-0.03M9.38M-0.03M-0.03M-0.03M-0.03M-0.01M
Net Debt Issuances and RepaymentsNet Debt Issuance
-0.58M-1.75M-1.75M-1.75M-1.75M-0.03M-0.03M9.38M-0.03M-0.03M-0.03M-0.03M-0.01M
Change in Capital Stock
Common Stock IssuedStock Issued
13.70M0.00M57.74M57.21M2.43M0.06M0.04M0.00M0.04M0.00M0.25M0.16M0.05M8.94M2.61M1.12M0.28M0.22M1.79M
Net Shares Issued and RepurchasedNet Shares Issued
13.70M0.00M57.74M57.21M2.43M0.06M0.04M0.00M0.04M0.00M0.25M0.16M0.05M8.94M2.61M1.12M0.28M0.22M1.79M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
13.70M0.00M57.74M57.21M2.43M0.06M0.04M0.00M0.04M0.00M0.25M0.16M0.05M8.94M2.61M1.12M0.28M0.22M1.79M
Other financing activitiesOther financing
-0.40M0.04M-0.04M-0.01M-0.16M-0.03M-0.02M-0.01M-0.17M-0.06M-0.22M-0.37M-0.22M
Cash from Financing ActivitiesCash from Financing
0.13M13.74M-0.63M55.98M55.30M0.65M-1.70M-7.66M1.51M-0.05M-0.03M5.07M4.98M51.47M8.71M110.40M1.63M0.28M0.22M164.36M
Additional items
Change in Cash
-7.11M7.51M-7.72M-4.42M41.88M-53.99M-0.94M2.10M12.21M6.43M-18.59M-0.85M3.09M18.05M-14.72M97.68M-60.19M-37.96M0.50M34.89M
Ending Cash Balance
29.32M36.83M29.11M24.70M66.57M12.59M11.65M13.75M25.97M32.40M13.81M12.96M16.05M34.10M19.37M117.06M56.87M18.91M19.41M54.30M
Free Cash FlowFCF
-7.24M-6.23M-7.09M-6.18M-8.58M-6.45M-8.25M-9.92M-7.30M-6.38M-10.47M-8.68M-9.56M-9.56M-13.48M-10.10M-10.89M-7.63M-16.79M-17.55M
Net Cash FlowNCF
-7.11M7.51M-7.72M49.80M41.88M-53.99M-0.94M2.10M12.21M6.43M-18.59M-0.85M3.09M18.05M-14.72M97.68M-60.19M-37.96M0.50M34.89M
Interest Paid

Trevi Therapeutics Cash Flow Statement API

Pull Trevi Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=TRVI&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY